<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0908233976
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Mixif
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFIXIME
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        400
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, hard
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        75.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DD08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Mixif&reg; capsules contain a medicine called cefixime. This belongs to a group of antibiotics called &lsquo;cephalosporins&rsquo;.<br />Mixif&reg; capsules are used to treat infections caused by bacteria. These include infections of the:<br />&bull; Ear<br />&bull; Nose, sinuses (such as sinusitis)<br />&bull; Throat (such as tonsillitis, pharyngitis)<br />&bull; Chest and lungs (such as bronchitis, pneumonia)<br />&bull; Urinary system (such as cystitis and kidney infections)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Mixif&reg; if:</strong><br />You are allergic to cefixime, any other cephalosporin antibiotics including penicillin or to any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of the lips, face, throat and tongue.</p><p><br />Do not take this medicine if the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Mixif&reg;.</p><p><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking Mixif&reg; if:<br />&bull; You have ever had colitis<br />&bull; You have kidney problems<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking this medicine.</p><p><br />Severe skin problems such as Toxic Epidermal Necrolysis (TEN), Stevens-Johnson Syndrome (SJS), Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), and Acute Generalised Exanthematous Pustulosis (AGEP) have been reported with cefixime (see section 4). If you develop severe skin reactions or any of the reactions listed in section 4, stop treatment immediately and contact your doctor or healthcare professional.</p><p><strong>Children</strong><br />Mixif&reg; capsules should not be given to children under 10 years old.<br />Other medicines and Mixif&reg;<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines you buy without a prescription, including herbal medicines. This is because Mixif&reg; can affect the way some other medicines work. Also, some medicines can affect the way Mixif&reg; works.<br />In particular, tell your doctor if you are taking the following:<br />&bull; Medicines to thin the blood such as warfarin</p><p><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Driving and using machines</strong><br />This medicine can cause symptoms including fits (convulsions), feeling confused, feeling less alert or aware of things than usual, unusual muscle movements or stiffness. If you experience any of these effects don&rsquo;t drive or use machinery.</p><p><strong>Medical Tests</strong><br />If you require any tests (such as blood or urine tests) while taking this medicine, please make sure your doctor knows that you are taking Mixif&reg;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Ask your pharmacist if you are not sure about the dose to take. The medicine should be taken for the prescribed number of days.</p><p>The recommended dose is:<br /><strong>Adults, Elderly and Children over 10 years or weighing more than 50kg</strong><br />&bull; 200 &ndash; 400 mg each day given as a single or divided dose.</p><p><strong>People with kidney problems</strong><br />&bull; Your doctor may prescribe a lower dose.<br /><strong>Children under 10 years old</strong><br />&bull; Mixif&reg; should not be given to children under 10 years old. Mixif&reg; suspension should be used instead</p><p><strong>Method of administration (SPC section 4.2)</strong><br />&bull; Take this medicine by mouth.<br />&bull; Swallow capsules whole with a drink of water.<br />&bull; If you feel the effect of the medicine is too weak or too strong, do not change the dose yourself, but ask your doctor.</p><p><strong>If you take more Mixif&reg; than you should</strong><br />If you have too much of this medicine, talk to your doctor straight away.<br /><strong>If you forget to take Mixif&reg;</strong><br />If you forget to take a dose, take it as soon as you remember it. However, if it is nearly time for the next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.<br /><strong>If you stop taking Mixif&reg;</strong><br />Do not stop taking this medicine without talking to your doctor. You should not stop taking Mixif&reg; just because you feel better. This is because the infection may come back or get worse again.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Tell your doctor straight away or go to the nearest hospital casualty department if you notice any of the following serious side effects &ndash; you may need urgent medical treatment:</strong></p><p>&bull; You have an allergic reaction. The signs may include: a rash, joint pain, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>&bull; SJS/TEN symptoms may include blistering, peeling or bleeding on any part of the skin (including the lips, eyes, mouth, nose, genitals, hands or feet). Also, flu-like symptoms such as fever, chills or aching muscles.<br />&bull; DRESS symptoms may include flu-like symptoms and a widespread rash with a high body temperature and enlarged lymph nodes. Abnormal blood test results may include increased levels of liver enzymes and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes.<br />&bull; AGEP symptoms may include a red, scaly, widespread rash with bumps under the skin (including your skin folds, chest, abdomen (including stomach), back and arms) and blisters accompanied by fever.<br />&bull; Erythema multiforme symptoms include skin rash or skin lesions with a pink/red ring and a pale centre which may be itchy, scaly or filled with fluid. The rash may appear especially on the palms or soles of your feet.<br />&bull; You get infections more easily than usual. This could be because of a blood disorder. This normally gets better after stopping the medicine.<br />&bull; You bruise or bleed more easily than normal. This could be because of a blood disorder. This normally gets better after stopping the medicine.<br />&bull; If your child gets nose bleeds, bleeding gums, chills, tiredness, pale skin (often with a yellow tinge), shortness of breath. This may be due to haemolytic anaemia.<br />&bull; Changes in the way the kidneys are working or blood in your child&rsquo;s urine.<br />&bull; Fits (convulsions)<br />&bull; A brain condition with symptoms including fits (convulsions), feeling confused, feeling less alert or aware of things than usual, unusual muscle movements or stiffness. This may be something called encephalopathy. This side effect is more likely if you have taken an overdose or you already have a problem with your kidneys.</p><p><strong>Stop taking this medicine and contact your doctor without delay if you get:</strong><br />&bull; Severe watery diarrhoea that will not stop and you are feeling weak and have a fever. This may be something called &lsquo;Pseudomembranous colitis&rsquo;.</p><p><strong>Tell your doctor or pharmacist if any of the following side effects get serious or lasts longer than a few days:</strong><br />&bull; Feeling sick (nausea) or being sick (vomiting)<br />&bull; Stomach pains, indigestion or wind<br />&bull; Headaches<br />&bull; Feeling dizzy<br />&bull; Feeling itchy in the genital or vaginal area</p><p><strong>Blood tests</strong><br />Cefixime can cause blood clots or small changes to the way the liver and kidney work. This would be shown up in blood tests. This is not common and goes back to normal after stopping this medicine.<br /><strong>Reporting of side effects</strong><br />If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not use Mixif&reg; capsules after the expiry date, which is stated on the carton. The expiry date refers to the last day of that month.<br />&bull; Do not store above 30&deg;C.<br />&bull; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Mixif&reg; capsules contains 200 mg or 400 mg cefixime (as cefixime trihydrate).<br />Inactive ingredients: Sodium starch glycolate, magnesium stearate and pregelatinized starch.<br />Mixif&reg; capsules are packed in PVC/Aluminum blisters. These blisters are available in carton outer packs along with patient information leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Mixif® 200 are capsules with white opaque body coded (CAP009) and Brown opaque cap coded (DAD).
Mixif® 400 are capsules with white opaque body coded (CAP010) and brown opaque cap coded (DAD).
Mixif® 200 capsules are available in packs of 8 (1 blister of 8).
Mixif® 400 capsules are available in packs of 5 (1 blister of 5) and 10 (2 blisters of 5).
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment Co. Ltd.<br />Prince Hashem Bin Al-Hussein Street.<br />Na&rsquo;ur - Amman &ndash; Jordan<br />Tel. (+962 6) 57 27 132<br />Fax. (+962 6) 57 27 776</p><p><strong>To report any side effects:</strong><br /><strong>&bull; Jordan</strong><br />Jordan Food and Drug Administration<br />&minus; Phone :+962 6 5632000<br />&minus; Website: www.jfda.jo<br />&minus; reporting link https://primaryreporting.who-umc.org/jo<br />&minus; Email: jpc@jfda.jo</p><p><br /><strong>&bull; Saudi Arabia</strong><br />The National Pharmacovigilance Centre (NPC)<br />&minus; SFDA Call Centre: 19999<br />&minus; E-mail: npc.drug@sfda.gov.sa<br />&minus; Website: www.sfda.gov.sa/npc</p><p><br /><strong>&bull; United Arab Emirates</strong><br />Pharmacovigilance and Medical Device Section<br />&minus; Drug Department<br />&minus; UAE Ministry of Health &amp; Prevention<br />&minus; Hotline: 80011111<br />&minus; Email: pv@moh.gov.ae<br />&minus; P.O. Box: 1853 Dubai UAE</p><p><br /><strong>&bull; Sudan</strong><br />National Medicines and Poisons Board (NMPB)<br />&minus; Fax: + 249 183522263<br />&minus; E-mail: info@nmpb.gov.sd<br />&minus; Website : www.nmpb.gov.sd</p><p><br /><strong>&bull; Other countries</strong><br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>تحتوي كبسولات ميكسيف على دواء يدعى سفكسيم. ينتمي سفكسيم إلى مجموعة من المضادات الحيوية تسمى<br />&quot;السيفالوسبورينات&quot;.<br />يستخدم ميكسيف لعلاج العدوى التي تسببها البكتيريا. وهذه تشمل عدوى :<br />&bull; الأذ ن<br />&bull; الأنف، الجيوب( مثل التهاب الجيوب)<br />&bull; الحلق (التهاب اللوزتين، التهاب البلعوم)<br />&bull; الصدر والرئتين (التهاب الشعب الهوائية، الالتهاب الرئوي)<br />&bull; الجهاز البولي (التهاب المثانة، عدوى الكلى)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>موانع استخدام كبسولات ميكسيف</strong><br />اذا كان لديك فرط حساسية تجاه سفكسيم، أو أي من المضادات الحيوية الأخرى من السيفالوسبورينات<br />والبينسلين أو أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم 6). تشمل علامات حدوث تفاعل تحسسي:طفح جلدي، مشاكل في البلع أو التنفس، انتفاخ في الشفتين، الوجه، الحلق واللسان.</p><p>لا تتناول هذا الدواء في حال انطبق عليك أي مما ذكر سابق ا . إذا كنت غير متأكد، تحدث الى طبيبك أو الصيدلاني قبل تناول ميكسيف.</p><p><strong>الاحتياطات عند تناول كبسولات ميكسيف</strong><br />استشر طبيبك أو الصيدلي قبل تناول كبسولات ميكسيف في حال:<br />&bull; كنت تعاني مسبقا من التهاب القولون<br />&bull; تعاني من مشاكل في الكلى</p><p>اذا كنت غير متأكد إذا كان أي مما سبق ينطبق عليك، تحدث الى طبيبك أو الصيدلاني قبل تناول الدواء.<br />تم الإبلاغ عن حالات الإصابة بإنحلال البشرة السمي، ومتلازمة ستيفن جونسون، وطفح جلدي مصحوب بفرط الحمضات وأعراض جهازية، بالإضافة إلى بثار طفحي حاد متعمم حدثت عند تناول سفكسيم (انظر القسم 4 ). في حال تعرضت لتفاعلات جلدية شديدة أو لأي من التفاعلات المذكورة في القسم 4 ، توقف عن أخذ العلاج مباشرة وتواصل مع طبيبك أو مقدم الرعاية الطبية.</p><p><strong>الاطفال</strong><br />يمنع إعطاء كبسولات ميكسيف للأطفال دون 10 سنوات.</p><p><strong>التداخلات الدوائية من تناول ميكسيف مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong><br />أبلغ طبيبك أو الصيدلي إذا كنت تتناول او تناولت مؤخرا أو تنوي أن تتناول أي ادوية اخرى. بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية ومن ضمنها الأعشاب الطبية. وهذا لأن ميكسيف يؤثر على آلية عمل بعض الأدوية الأخرى. كما أن بعض الأدوية تؤثر على آلية عمل ميكسيف.<br />أخبر طبيبك في حال تناولت الأدوية التالية بشكل خاص:<br />&bull; الأدوية التي تستخدم لترقق الدم مثل الورفارين</p><p><strong>الحمل والرضاعة</strong><br />في حال كنت حامل أو مرضع، تعتقدين أنك حامل أو تخططين لحدوث حمل، اطلبي المشورة من طبيبك أو الصيدلي قبل تناول هذا الدواء .<br /><strong>القيادة واستخدام الآلات</strong><br />قد يسبب هذا الدواء أعراض تشمل النوبات(التشنجات)، الشعور بارتباك، تيقظ او انتباه للاشياء بدرجة اقل من الوضع المعتاد، حركات غير طبيعية للعضلات او تيبس. اذا تعرضت لأي من هذه الأعراض لا تقم بالقيادة او تشغيل الآلات.</p><p><strong>الفحوصات</strong><br />اذا كنت ستخضع لأي فحوصات مخبرية (مثل فحص الدم أو البول) خلال فترة استخدام الدواء، احرص على إعلام طبيبك بأنك تتناول ميكسيف</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء تماما كما أخبرك الطبيب. إستشر طبيبك أو الصيدلي إذا لم تكن متأكدا.<br />اسأل الصيدلاني اذا كنت غير متأكد من الجرعة المطلوبة. يجب الالتزام بتناول الدواء بحسب عدد الأيام التي أوصى بها الطبيب.<br />الجرعة الموصى بها هي:<br /><strong>الراشدين، كبار السن والأطفال الذين تزيد أعمارهم عن 10 سنوات أو يزيد وزنهم عن 50 كغم</strong><br />&bull; 200 &ndash; 400 ملغم يوميا ، تعطى كجرعة منفرة أو جرعات مقسمة .<br /><strong>الأشخاص الذين يعانون مشاكل الكلى</strong><br />&bull; قد يطلب الطبيب تناول جرعة أقل</p><p><strong>الأطفال الذين تقل أعمارهم عن 10 سنوات</strong><br />&bull; لا ينبغي إعطاء كبسولات ميكسيف للاطفال دون 10 سنوات. يستخدام معلق ميكسيف كبديل.<br /><strong>طريقة الاستخدام</strong><br />&bull; تناول هذه الدواء عن طريق الفم .<br />&bull; ابلع الكبسولة كاملة مع كأس من الماء<br />&bull; اذا كنت تشعر أن تأثير الدواء ضعيف جدا أو قوي جدا ، لا تغير الجرعة بنفسك ولكن اسأل الطبيب.</p><p><strong>الجرعة الزائدة من كبسولات ميكسيف</strong><br />إذا تناولت جرعة زائدة من الدواء، تحدث الى طبيبك مباشرة.<br /><strong>نسيان تناول جرعة كبسولات ميكسيف</strong><br />إذا نسيت تناول جرعة من هذا الدواء، قم بتناولها فور تذكرك. مع ذلك، إذا اقترب وقت الجرعة التالية، تخطى الجرعة المنسية. لا تقم بمضاعفة الجرعة للتعويض عن الجرعة التي نسيتها.<br /><strong>التوقف عن تناول كبسولات ميكسيف</strong><br />لا تتوقف عن تناول الدواء دون استشارة الطبيب. لا تتوقف عن تناول ميكسيف فقط لأنك شعرت بتحسن. وذلك لأنه من الممكن أن يسبب ذلك الإصابة بالعدوى من جديد أو تفاقمها.</p><p>إذا كان لديك أي إستفسارات اضافية تتعلق بهذا الدواء، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال في كل الادوية، هذا الدواء يمكن أن يتسبب بأعراض جانبية، بالرغم من من أنها قد لا تحدث للجميع.<br /><strong>أخبر طبيبك على الفور أو اذهب الى أقرب مركز طوارئ إذا لاحظت أي من الأعراض الجانبية الخطيرة التالية- قد تحتاج الى العناية الطبية الطارئة:</strong></p><p>&bull; اذا أصبت بتفاعل حساسية. تشمل العلامات: طفح جلدي، ألم المفاصل، مشاكل في البلع أو التنفس، تورم الشفاه، الوجه، الحلق أو اللسان .<br />&bull; متلازمة ستيفن جونسون/انحلال البشرة السمي، قد تشمل الاعراض تقرح، تقشير أو نزيف في أي جزء من الجلد(بما في ذلك الشفاه، العينين، الفم، الأنف، الأعضاء التناسلية، اليدين أو الأقدام). بالإضافة إلى أعراض تشبه الانفلونزا مثل الحمى، القشعريرة أو ألم العضلات .<br />&bull; أعراض متلازمة التفاعل الدوائ ي المصحوب بفرط الحمضات وأعراض جهازية والتي قد تتضمن أعراض تشبه الانفلونزا وطفح منتشر بشكل كبير مع ارتفاع درجة الحرارة وتضخم الغدد الليمفاوية. نتائج غير طبيعية لفحوصات الدم مثل ارتفاع مستوى انزيمات الكبد وزيادة في نوع محدد من خلايا الدم البيضاء (الحمضات) وتضخم الغدد الليمفاوية.<br />&bull; أعراض البثار الطفحي الحاد المتعمم التي قد تتضمن احمرار وتقشر طبقات من الجلد وطفح منتشر على مساحات واسعة بالاضافة إلى كدمات تحت الجلد (تشمل طيات الجلد، الصدر، البطن(بما في ذلك المعده)&nbsp;الظهر والذراعين) بالإضافة إلى تقرحات مصحوبة بحمى.<br />&bull; حمامي متعدد الاشكال يتضمن طفح جلدي أو إصابات جلدية مصحوبة بحلقات وردية/حمراء مركزها باهت اللون قد تسبب حكة، تقشر أو قد تكون مليئة بسائل. من الممكن أن يظهر الطفح في راحة اليدين أو باطن القدمين على وجه الخصوص.<br />&bull; أصبحت أكثر عرضة للإصابة بالعدوى. قد يكون هذا بسبب اضطراب في الدم. في العادة تتحسن حالتك بعد التوقف عن تناول الدواء<br />&bull; أصبحت أكثر عرضة للإصابة بكدمات أو نزيف. قد يكون ذلك بسبب اضطراب في الدم. عادة تتحسن حالتك عند التوقف عن تناول الدواء.</p><p>&bull; في حال أصيب طفلك بنزيف في الانف، نزيف في اللثة، قشعريرة، تعب، شحوب (مع أصفرار باهت)، قصر في التنفس. من الممكن ان يكون ذلك بسبب فقر الدم الانحلالي.<br />&bull; تغيرات في طريقة عمل الكلى أو وجود دم في بول طفلك.<br />&bull; نوبات (تشنجات)<br />&bull; حالة دماغية مع أعراض تشمل حدوث النوبات(تشنجات)، الشعور بارتباك، عدم التيقظ الا نتباه للاشياء كالمعتاد، حركات غير طبيعية للعضلات او تيبس. قد تسمى هذه الحالة اعتلال دماغي. يكون هذا الاثر الجانبي أكثر احتمالا اذا تناولت جرعة زائدة او كان لديك مسبقا مشكلة في الكلى.</p><p><strong>توقف عن تناول الدواء وتواصل مع طبيبك دون تأخير في حال:</strong><br />&bull; الإصابة بإسهال شديد، مائي طويل الأمد يرافقه شعور بالضعف مع حمى. قد يكون ما يدعى ب &quot;التهاب القولون الغشائي الكاذب&quot;.</p><p><strong>تحدث الى طبيبك أو الصيدلاني في حال أصبحت الأعراض الجانبية التالية خطيرة أو دامت لمدة أطول من عدة أيام</strong><br />&bull; غثيان أو تقيؤ<br />&bull; آلام في المعدة، عسر الهضم أو ريح<br />&bull; صدا ع<br />&bull; الشعور بالدوار<br />&bull; الشعور بالحكة في المنطقة التناسلية أو منطقة المهبل</p><p><strong>فحوصات الدم</strong><br />قد يسبب سفكسيم جلطات دم أو تغيرات صغيرة على طريقة عمل الكبد والكلى. ويظهر ذلك في فحوصات الدم ولكنه غير شائع ويعود لوضعه الطبيعي بعد وقف الدواء.</p><p><strong>الإبلاغ عن الأعراض الجانبية</strong><br />إن كان لديك أعراض جانبية أو لاحظت أعراض جانبية غير مذكورة في هذه النشرة، فضلا أبلغ الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; يحفظ بعيدا عن متناول ايدي الأطفال نظرهم.<br />&bull; لا تستخدم كبسولات ميكسيف بعد تاريخ الانتهاء المذكور على العبوة الخارجية. يدل تاريخ الانتهاء على اخر يوم في الشهر المذكور .<br />&bull; يحفظ على درجة حرارة لا تزيد عن 30 درجة مئوية.<br />&bull; لا تتخلص من الدواء عن طريق رميه في مياه الصرف الصحي أو النفايات المنزلية. إسأل الصيدلي عن كيفية التخلص من الدواء إذا لم تعد بحاجته. هذه الاجراءات تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تحتوي كبسولات ميكسيف على 200 أو 400 ملغم سفكسيم(على هيئة سفكسيم ثلاثي الماء).<br />المواد غير الفعالة: أملاح الصوديوم لجليكولات النشا، ستيارات المغنيسيوم، نشا غير مهيلم.<br />يتم تغليف كبسولات ميكسيف في أشرطة من البلاستيك والألمنيوم. تعبأ هذه الاشرطة في عبوات كرتونية مع نشرة معلومات المريض.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما هو الشكل الصيدلاني لكبسولات ميكسيف ووصفه وحجم عبوته</strong></p><p>ميكسيف 200 هو عبارة عن كبسولات لونها أبيض غير شفافة مرمزة بالرمز ( CAP009 ) لها غطاء لونه بني غير شفاف مرمز بالرمز ( DAD)<br />ميكسيف 400 هو عبارة عن كبسولات لونها أبيض غير شفافة مرمزة بالرمز ( CAP010 ) لها غطاء لونه بني غير شفاف مرمز بالرمز ( DAD)<br />تتوفر كبسولات ميكسيف 200 في عبوات من 8 (شريط يحتوي على 8 ) كبسولات.<br />تتوفر كبسولات ميكسيف 400 في عبوات من 5 (شريط يحتوي على 5 ) 10 (شريطين يحتوي كل منهما على 5 ) كبسولات.<br />قد لا يتم تسويق جميع العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة دار الدواء للتنمية والإستثمار المساهمة المحدودة<br />شارع الأمير هاشم بن الحسين<br />ناعور &ndash; عمان &ndash; الأردن<br />هاتف: 132 27 57 ( 6 962 ) +<br />فاكس: 776 27 57 ( 6 962 ) +</p><p>&nbsp;</p><p><strong>للإبلاغ عن الأعراض&nbsp;الجانبية :</strong><br /><strong>&bull; الأردن</strong><br />المؤسسة العامة للغذاء والدوا ء<br />&minus; الرقم:&nbsp; 96265632000+<br />&minus; الموقع الالكتروني: www.jfda.jo<br />&minus; رابط التبليغ: https://primaryreporting.who.umc.org.jo<br />&minus; البريد الالكتروني: jpc@jfda.jo</p><p><br /><strong>&bull; المملكة العربية السعودية</strong><br />المركز الوطني للتيقظ والسلامة الدوائية<br />&minus; الرقم الموحد 19999<br />&minus; البريد الالكتروني: npc.drug@sfda.gov.sa<br />&minus; الموقع الالكتروني: www.sfda.gov.sa/npc&nbsp;<br />&nbsp;</p><p><strong>&bull; الإمارات العربية المتحدة</strong><br />قسم اليقظة الدوائية والوسائل الطبية<br />إدارة الدواء<br />وزارة الصحة ووقاية المجتمع<br />&minus; الخط الساخن : 80011111<br />&minus; ايميل : pv@mohap.gov.ae<br />&minus; صندوق بريد : 1853 دبي الامارات العربية المتحدة</p><p><br /><strong>&bull; السودان</strong><br />المجلس القومي للأدوية والسموم<br />&minus; فاكس: 522263 183 ( 249 )+<br />&minus; البريد الإلكتروني: info@nmpb.gov.sd<br />&minus; الموقع الإلكتروني: www.nmpb.gov.sd</p><p><br /><strong>&bull; الدول الأخرى</strong><br />&minus; الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mixif 400 mg capsules

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mixif 400 capsules: Each capsule contains 400 mg Cefixime (as cefixime trihydrate).
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsules
Mixif 400 capsules are capsules with white opaque body coded (CAP010) and brown opaque cap coded (DAD).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mixif is an orally active cephalosporin antibiotic which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.</p><p>It is indicated in adults and children over 10 years or weighing more than 50 kg for the treatment of the following acute infections when caused by susceptible micro-organisms: Upper Respiratory Tract Infections (URTI): e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk.</p><p><u>Lower Respiratory Tract Infection</u>: e.g. bronchitis.</p><p><u>Urinary Tract Infections</u>: e.g. cystitis, cystourethritis, uncomplicated pyelonephritis</p><p>Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Kliebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Branhamella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Mixif is highly stable in the presence of beta-lactamase enzymes.</p><p>Most strains of enterococci (Streptococcus faecalis, group D Streptococci) and Staphylococci (including coagulase positive and negative strains and methicillin-resistant strains) are resistant to cefixime. In addition, most strains of Pseudomonas, Bacteriodes fragalis, Listeria monocytogenes and Clostridia are resistant to cefixime.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The usual course of treatment is 7 days. This may be continued for up to 14 days if required.</p><p><strong>Posology</strong></p><p><strong>Adults and Children over 10 years or weighing more than 50 kg:</strong></p><p>The recommended dose is 200 &ndash; 400 mg daily according to the severity of infection, given either as a single dose or in two divided doses.</p><p><strong>Pediatric population </strong></p><p><strong>Children under 10 years:</strong></p><p>Mixif capsules are not recommended for use in children under 10 years old. The safety and efficacy of cefixime has not been established in children less than 6 months.</p><p><strong>Elderly:</strong></p><p>Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed, and dosage should be adjusted in severe renal impairment.</p><p><strong>Renal impairment</strong>:</p><p>Mixif may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.</p><p><strong>Method for administration</strong></p><p>For oral administration. Absorption of cefixime is not significantly modified by the presence of food</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to cephalosporin antibiotics or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Encephalopathy</strong></p><p>Beta-lactams, including cefixime, predispose the patient to encephalopathy risk (which may include convulsions, confusion, impairment of consciousness, movement disorders), particularly in case of overdose or renal impairment.</p><p><strong>Severe cutaneous adverse reactions</strong></p><p>Severe cutaneous adverse reactions (SCARS) including toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS) drug rash with eosinophilia and systemic symptoms (DRESS), and acute generalised exanthematous pustulosis (AGEP) have been reported in association with cefixime. Patients should be informed about the signs and symptoms of serious skin manifestations and monitored closely. Treatment should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of skin hypersensitivity.</p><p>Mixif should be given with caution to patients who have shown hypersensitivity to other drugs.</p><p><strong>Hypersensitivity to penicillins</strong></p><p>As with other cephalosporins, cefixime should be given with caution to patients with a history of hypersensitivity to penicillin, as there is some evidence of partial cross-allergenicity between the penicillins and cephalosporins.</p><p>Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Mixif, the drug should be discontinued and the patient treated with appropriate agents if necessary.</p><p><strong>Haemolytic anaemia</strong></p><p>Drug-induced haemolytic anaemia, including severe cases with a fatal outcome, has been described for cephalosporins (as a class). The recurrence of haemolytic anaemia after re-administration of cephalosporins in a patient with a history of cephalosporin (including cefixime) &ndash;associated haemolytic anaemia has also been reported.</p><p><strong>Acute renal failure</strong></p><p>As with other cephalosporins, cefixime may cause acute renal failure including tubulointerstitial nephritis as an underlying pathological condition. When acute renal failure occurs, cefixime should be discontinued and appropriate therapy and/or measures should be taken.</p><p><strong>Renal impairment</strong></p><p>Mixif should be administered with caution in patients with markedly impaired renal function (see section 4.2).</p><p><strong>Paediatric use</strong></p><p>Safety of cefixime in premature or newborn infant has not been established (see section 4.2).</p><p><strong>Antibiotic-associated colitis</strong></p><p>Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Pseudomembranous colitis is associated with the use of broad-spectrum antibiotics (including macrolides, semi-synthetic penicillins, lincosamides and cephalosporins); it is therefore important to consider its&nbsp;diagnosis in patients who develop diarrhoea in association with the use of antibiotics. Symptoms of pseudomembranous colitis may occur during or after antibiotic treatment.</p><p>Management of pseudomembranous colitis should include sigmoidoscopy, appropriate bacteriologic studies, fluids, electrolytes and protein supplementation. If the colitis does not improve after the drug has been discontinued, or if the symptoms are severe, oral vancomycin is the drug of choice for antibiotic-associated pseudomembranous colitis produced by C. difficile. Other causes of colitis should be excluded.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Anticoagulants</strong></p><p>In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulation therapy.</p><p>Cefixime should be administered with caution to patients receiving coumarin-type anticoagulants, e.g. warfarin potassium. Since cefixime may enhance effects of the anticoagulants, prolonged prothrombin time with or without bleeding may occur.</p><p><strong>Other forms of interaction</strong></p><p>A false positive reaction for glucose in the urine may occur with Benedict&#39;s or Fehling&#39;s solutions or with copper sulphate test tablets, but not with tests based on enzymatic glucose oxidase reactions.</p><p>A false positive direct Coombs test has been reported during treatment with cephalosporin antibiotics, therefore it should be recognised that a positive Coombs test may be due to the drug.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reproduction studies have been performed in mice and rats at doses up to 400 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to cefixime. In the rabbit, at doses up to 4 times the human dose, there was no evidence of a teratogenic effect; there was a high incidence of abortion and maternal death which is an expected consequence of the known sensitivity of rabbits to antibiotic-induced changes in the population of the microflora of the intestine.</p><p>There are no adequate and well-controlled studies in pregnant women. Mixif should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the case of side effects such as encephalopathy (which may include convulsion, confusion, impairment of consciousness, movement disorders), the patient should not operate machines or drive a vehicle.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Tabulated list of adverse reactions</strong></p><p>Cefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self-limiting in nature.</p><p>The following adverse reaction (Preferred term# or equivalent) will be considered listed:</p><table border="1" cellspacing="1" cellpadding="1" style="width:841px"><tbody><tr><td>Blood and lymphatic system disorders:</td><td style="width:341px">Eosinophilia<br />Hypereosinophilia<br />Agranulocytosis<br />Leucopenia<br />Neutropenia<br />Granulocytopenia<br />Haemolytic anaemia<br />Thrombocytopenia<br />Thrombocytosis</td></tr><tr><td>Gastrointestinal disorders:</td><td style="width:341px">Abdominal pain<br />Diarrhoea*<br />Dyspepsia<br />Nausea<br />Vomiting<br />Flatulence</td></tr><tr><td>Hepatobiliary disorders:</td><td style="width:341px">Jaundice</td></tr><tr><td>Infections and infestations</td><td style="width:341px">Pseudomembranous colitis<br />Vaginitis</td></tr><tr><td>Investigations:</td><td style="width:341px">Aspartate aminotransferase increased<br />Alanine aminotransferase increased<br />Blood bilirubin increased<br />Blood urea increased<br />Blood creatinine increased</td></tr><tr><td>Nervous system disorders:</td><td style="width:341px">Dizziness<br />Headache<br />Cases of convulsions have been reported with cephalosporins including cefixime (frequency not known)**<br />Beta-lactams, including cefixime, predispose the patient to encephalopathy risk (which may include convulsions, confusion, impairment of consciousness, movement disorders), particularly in case of overdose or renal impairment (frequency not known)**</td></tr><tr><td>Respiratory, thoracic and mediastinal disorders:</td><td style="width:341px">Dyspnoea</td></tr><tr><td>Renal and urinary disorders:</td><td style="width:341px">Acute renal failure with tubulointerstitial nephritis (see section 4.4).</td></tr><tr><td>Immune system disorders:</td><td style="width:341px">Anaphylactic reaction<br />Angio-oedema<br />Serum sickness-like reaction</td></tr><tr><td>Skin and subcutaneous tissue disorders:</td><td style="width:341px"><p>Drug rash with eosinophilia and systemic symptoms (DRESS)</p><p>Erythema multiforme<br />Stevens-Johnson syndrome<br />Toxic epidermal necrolysis<br />Urticaria<br />Rash<br />Pruritus<br />Acute generalised exanthematous pustulosis(AGEP) (see section 4.4)</p></td></tr><tr><td>General disorders and administrative site conditions:</td><td style="width:341px">Drug Fever<br />Arthralgia<br />Pyrexia<br />Face oedema<br />Genital pruritus</td></tr></tbody></table><p>The above mentioned listed adverse reactions have been observed during clinical studies and/or during marketed use.</p><p># Preferred term in MedDRA (v.14.0)</p><p>*Diarrhoea has been more commonly associated with higher doses. Some cases of moderate to severe diarrhoea have been reported; this has occasionally warranted cessation of therapy. Mixif should be discontinued if marked diarrhoea occurs.</p><p>**Cannot be estimated from available data</p><p><strong>To report any side effect(s): </strong></p><p><strong>Saudi Arabia</strong></p><p>The National Pharmacovigilance Centre (NPC):<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa<br />&nbsp;</p><p><strong>Other GCC States:</strong></p><ul><li>Please contact the relevant competent authority</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is a risk of encephalopathy in cases of administration of beta-lactam antibiotics, including cefixime, particularly in case of overdose or renal impairment.</p><p>Adverse reactions seen at dose levels up to 2 g cefixime in normal subjects did not differ from the profile seen in patients treated at the recommended doses. Cefixime is not removed from the circulation in significant quantities by dialysis.</p><p>No specific antidote exists. General supportive measures are recommended</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: third generation cephalosporin, ATC code: J01DD08</p><p>Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.</p><p>Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Branhamella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. It is highly stable in the presence of beta-lactamase enzymes.</p><p>Most strains of enterococci (Streptococcus faecalis, group D Streptococci) and Staphylococci (including coagulase positive and negative strains and methicillin-resistant strains) are resistant to cefixime. In addition, most strains of Pseudomonas, Bacteroides fragilis, Listeria monocytogenes and Clostridia are resistant to cefixime.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The absolute oral bioavailability of cefixime is in the range of 22 &ndash; 54%. Absorption is not significantly modified by the presence of food. Cefixime may therefore be given without regard to meals.</p><p>From in vitro studies, serum or urine concentrations of 1 mcg/mL or greater were considered to be adequate for most common pathogens against which cefixime is active. Typically, the peak serum levels following the recommended adult or paediatric doses are between 1.5 &ndash; 3 mcg/ml. Little or no accumulation of cefixime occurs following multiple dosing.</p><p>The pharmacokinetics of cefixime in healthy elderly (age &gt; 64 years) and young volunteers (11 &ndash; 35) compared the administration of 400 mg doses once daily for 5 days. Mean Cmax and AUC values were slightly greater in the elderly. Elderly patients may be given the same dose as the general population.</p><p>Cefixime is predominantly eliminated as unchanged drug in the urine. Glomerular filtration is considered the predominant mechanism. Metabolites of cefixime have not been isolated from human serum or urine.</p><p>Serum protein binding is well characterised for human and animal sera; cefixime is almost exclusively bound to the albumin fraction, the mean free fraction being approximately 30%. Protein binding of cefixime is only concentration dependent in human serum at very high concentrations which are not seen following clinical dosing.</p><p>Transfer of 14C-labelled cefixime from lactating rats to their nursing offspring through breast milk was quantitatively small (approximately 1.5% of the mothers&#39; body content of&nbsp;cefixime in the pup). No data are available on secretion of cefixime in human breast milk. Placental transfer of cefixime was small in pregnant rats dosed with labelled cefixime.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre-clinical data of relevance to the prescriber, which are additional to that already included in other sections of the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Sodium starch glycolate</li><li>Magnesium stearate</li><li>Pregelatinized starch.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="1" cellpadding="1" style="width:793px"><tbody><tr><td><strong>Immediate packaging</strong></td><td style="width:295px"><strong>Outer packaging</strong></td></tr><tr><td>PVC / PVDC</td><td style="width:295px">Cardboard box</td></tr><tr><td>Aluminum foil</td><td style="width:295px">&nbsp;</td></tr></tbody></table><p>Mixif 400 capsules are available in aluminum packs of 5 (1 blister of 5) or 10 (2 blisters of 5).<br />Not all pack sizes may be marketed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
P.O. Box 9364
Na'ur – Amman – Jordan
Tel. (+962 6) 57 27 132
Fax. (+962 6) 57 27 776
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>